Clinical trial · Interventional
An Acupuncture Study for Cancer Survivors With Joint Pain
Researching the Implementation of Acupuncture for Chronic Musculoskeletal Pain in Diverse Underserved Cancer Survivors (ReIMAGINE)
NCT06814977CI-TRIAL-00096482recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to see whether acupuncture is a practical (feasible) treatment for cancer survivors with joint pain.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Survivor | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Acupuncture | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Acupuncture
- description
- Participants will receive 10 weekly acupuncture treatments over 10 weeks.
- interventionNames
- Procedure: Acupuncture
- type
- NO_INTERVENTION
- label
- Usual Care
- description
- Participants will receive standard medical care, including pain medications and other treatments
Primary outcomes (1)
- measure
- Study feasibility as measured by rates of enrollment
- timeFrame
- 1 year
- description
- The primary purpose of this study is to determine the feasibility of studying an acupuncture intervention for chronic musculoskeletal pain in racially/ethnically diverse, community-based cancer survivors.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * English- or Spanish-speaking adults * Non white or Hispanic women with a prior cancer diagnosis * Stable oncological disease or no evidence oncological of disease per clinical documentation or clinician assessment * Worst pain rated ≥4 on a 0-10 scale in the preceding week * ≥15 days with pain in the past 30 days * Pain lasting ≥1 month * Willing and able to complete questionnaires and other study activities * Willing and able to provide informed consent for the trial Exclusion Criteria: * Completed active treatment (chemotherapy, surgery, radiation, transplantation) \<4 weeks prior to study * Maintenance therapies are allowed * Pain attributed to inflammatory arthritis (e.g., rheumatoid arthritis, gout) * Other non-musculoskeletal pain syndromes (eg, headache, visceral abdominal pain, neuropathic pain) can be present as comorbid conditions if the patient reports musculoskeletal pain as the primary source of pain * Procedures involving affected joints within the last month or planned in the next 14 weeks * Acupuncture use for pain in the past three months * Implanted electronic device (e.g., pacemaker)
References
Publications (0)
Data not yet available
No reference posted for this study.